serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Published 2 months ago • 153 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
0:49
unmet needs for patients with prostate cancer
-
2:46
first-line treatments in metastatic prostate cancer
-
1:17
abiraterone for the treatment of cn1 prostate cancer
-
5:37
177lu-psma-617 for the early treatment of prostate cancer
-
1:10
unmet needs in immunotherapy for prostate cancer
-
2:10
current standards for first-line metastatic hormone-sensitive prostate cancer
-
2:25
diagnosing prostate cancer - yale medicine explains
-
2:39
dr. hussain on ets gene fusions as a predictive biomarker in prostate cancer
-
3:07
psma-trt, 225ac-j591 and 177lu-psma i&t in mcrpc
-
3:04
benefits of t1 substaging for nmibc
-
1:35
unmet needs in mhspc
-
0:36
what are the current unmet needs in anal cancer?
-
0:41
unmet clinical needs for muscle-invasive bladder cancer
-
4:48
overview of the final analysis of the phase iii tourmaline-mm1 trial
-
2:32
dr. goetz on treatment challenges for esr1-mutant breast cancer
-
1:46
long term aes in psma-trt
-
27:23
the nuts and bolts of clinical trials